Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients

By Wylie J.   Hajeer A. H.   West C.   Stewart A.   Magee B.   Kumar S.   Quarmby S.   Fakhoury H.   Levine E.   Barber J.  

International Journal of Radiation Biology, Vol. 79, Iss. 2, 2003-02 ,pp. : 137-143

Informa Healthcare

Access to resources Recommend Favorite

Correlation between plasma transforming growth factor- 1 and second primary breast cancer in a chemoprevention trial

By Decensi A.   Torrisi R.   Fontana V.   Barreca A.   Ponzani P.   Pensa F.   Parodi S.   Costa A.  

European Journal of Cancer, Vol. 34, Iss. 7, 1998-06 ,pp. : 999-1003

Elsevier

Access to resources Recommend Favorite

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

By Groves Morris   Hess Kenneth   Puduvalli Vinay   Colman Howard   Conrad Charles   Gilbert Mark   Weinberg Jeffrey   Cristofanilli Massimo   Yung W.   Liu Ta-Jen  

Journal of Neuro-Oncology, Vol. 94, Iss. 2, 2009-09 ,pp. : 229-234

Springer Publishing Company

Access to resources Recommend Favorite

Vascular endothelial growth factor (VEGF) levels and mutation of the BRCA1 gene in breast cancer patients

By Tarnowski B.  

Breast Cancer Research and Treatment, Vol. 88, Iss. 3, 2004-12 ,pp. : 287-288

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma

By            

Molecular Medicine Reports, Vol. 11, Iss. 6, 2015-01 ,pp. : 4508-4512

Spandidos Publications

Access to resources Recommend Favorite